Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi‐centre, randomised, double‐blinded, placebo‐controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi‐centre, randomised, double‐blinded, placebo‐controlled trial

Published:2016-03-20 Issue:4 Volume:70 Page:302-311
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Oh B.¹,Choi W. S.²,Park S. B.³,Cho B.⁴,Yang Y. J.⁵^ORCID,Lee E. S.⁵,Lee J. H.⁵

Affiliation:

1. Department of Family Medicine SMG‐SNU Boramae Hospital School of Medicine Seoul National University Seoul Korea

2. Department of Family Medicine Seoul St. Mary's Hospital College of Medicine The Catholic University of Korea Seoul Korea

3. Department of Family Practice and Community Health Ajou University Hospital School of Medicine Ajou University Suwon Korea

4. Department of Family Medicine Seoul National University Hospital School of Medicine Seoul National University Seoul Korea

5. Department of Health Promotion Center Ilsan Paik Hospital School of Medicine Inje University Goyang Korea

Funder

Daewoong Pharmaceutical Company

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12790

Reference31 articles.

1. Mechanisms and management of fatigue in progressive neurological disorders

2. Feelings of fatigue and psychopathology: A conceptual history

3. Biological mechanisms of chronic fatigue

4. New therapeutical indications of ursodeoxycholic acid;Copaci I;Rom J Gastroenterol,2005

5. Ursodeoxycholic acid in the treatment of liver diseases.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cross-cultural translation and validation of the Korean version of checklist individual strength (CIS) in the Korean working age population;International Journal of Industrial Ergonomics;2023-11

2. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases;Translational Neurodegeneration;2022-06-04

3. CORRECTION OF INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC HEPATITIS C AGAINST THE BACKGROUND OF NON-ALCOHOLIC FATTY LIVER DISEASE;Bulletin of Problems Biology and Medicine;2022

4. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland;European Journal of Gastroenterology & Hepatology;2021-11-01

5. Efficacy of ursodeoxycholic acid in nonalcoholic fatty liver disease: An updated meta-analysis of randomized controlled trials;ASIA PAC J CLIN NUTR;2020